Related Experiment Videos
[Graft versus host disease and cytokines]
1First Department of Internal Medicine, Nihon University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 1, 2003
Summary
Allogeneic stem cell transplants can cure blood cancers, but graft versus host disease (GVHD) is a major hurdle. This review explores how cytokines drive GVHD, impacting transplant success.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Context:
- Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a crucial treatment for hematological malignancies.
- Graft versus host disease (GVHD) poses a significant challenge to successful Allo-HSCT outcomes.
- Recent advancements in immunology and molecular biology have enhanced our understanding of GVHD pathogenesis.
Purpose:
- To review the intricate role of cytokines in the pathogenesis of GVHD.
- To elucidate the sequential steps of GVHD, focusing on cytokine dysregulation.
- To discuss the interaction between cytokines and cellular effectors in GVHD.
Summary:
- GVHD pathogenesis involves inappropriate cytokine production and a dysregulated cytokine network.
- These cytokine imbalances occur across three critical phases: conditioning, donor T cell activation, and effector mechanisms.
- Understanding these cytokine-mediated interactions is key to mitigating GVHD.
Impact:
- Provides insights into the molecular mechanisms underlying GVHD.
- Highlights the importance of cytokine networks in Allo-HSCT complications.
- Informs potential therapeutic strategies targeting cytokine pathways to improve transplant outcomes.